262 related articles for article (PubMed ID: 18559949)
1. Genes contributing to prion pathogenesis.
Tamgüney G; Giles K; Glidden DV; Lessard P; Wille H; Tremblay P; Groth DF; Yehiely F; Korth C; Moore RC; Tatzelt J; Rubinstein E; Boucheix C; Yang X; Stanley P; Lisanti MP; Dwek RA; Rudd PM; Moskovitz J; Epstein CJ; Cruz TD; Kuziel WA; Maeda N; Sap J; Ashe KH; Carlson GA; Tesseur I; Wyss-Coray T; Mucke L; Weisgraber KH; Mahley RW; Cohen FE; Prusiner SB
J Gen Virol; 2008 Jul; 89(Pt 7):1777-1788. PubMed ID: 18559949
[TBL] [Abstract][Full Text] [Related]
2. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
3. From prion diseases to Alzheimer's disease.
Hsiao KK
J Neural Transm Suppl; 1997; 49():135-44. PubMed ID: 9266423
[TBL] [Abstract][Full Text] [Related]
4. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
Kupfer L; Eiden M; Buschmann A; Groschup MH
Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
[TBL] [Abstract][Full Text] [Related]
5. Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein.
Race B; Phillips K; Meade-White K; Striebel J; Chesebro B
J Virol; 2015 Jun; 89(11):6022-32. PubMed ID: 25810548
[TBL] [Abstract][Full Text] [Related]
6. The role of PrP in health and disease.
Flechsig E; Weissmann C
Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
[TBL] [Abstract][Full Text] [Related]
7. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
[TBL] [Abstract][Full Text] [Related]
8. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
9. Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.
Chesebro B; Race B; Meade-White K; Lacasse R; Race R; Klingeborn M; Striebel J; Dorward D; McGovern G; Jeffrey M
PLoS Pathog; 2010 Mar; 6(3):e1000800. PubMed ID: 20221436
[TBL] [Abstract][Full Text] [Related]
10. Transgenetic investigations of prion diseases of humans and animals.
Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):239-54. PubMed ID: 8097053
[TBL] [Abstract][Full Text] [Related]
11. Sod1 deficiency reduces incubation time in mouse models of prion disease.
Akhtar S; Grizenkova J; Wenborn A; Hummerich H; Fernandez de Marco M; Brandner S; Collinge J; Lloyd SE
PLoS One; 2013; 8(1):e54454. PubMed ID: 23349894
[TBL] [Abstract][Full Text] [Related]
12. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
13. Developmental influence of the cellular prion protein on the gene expression profile in mouse hippocampus.
Benvegnù S; Roncaglia P; Agostini F; Casalone C; Corona C; Gustincich S; Legname G
Physiol Genomics; 2011 Jun; 43(12):711-25. PubMed ID: 21406608
[TBL] [Abstract][Full Text] [Related]
14. PrP knock-out and PrP transgenic mice in prion research.
Weissmann C; Flechsig E
Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
[TBL] [Abstract][Full Text] [Related]
15. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
16. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
17. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
[TBL] [Abstract][Full Text] [Related]
18. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
19. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.
Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S
Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815
[TBL] [Abstract][Full Text] [Related]
20. No superoxide dismutase activity of cellular prion protein in vivo.
Hutter G; Heppner FL; Aguzzi A
Biol Chem; 2003 Sep; 384(9):1279-85. PubMed ID: 14515989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
